Brief: Hyundai Pharmaceutical to raise 13 bln won via rights issue
Sept 25 (Reuters) - Hyundai Pharmaceutical Co Ltd
004310.KS :
* Says it plans to issue 4 million shares of the company via
rights issue, to raise 13 billion won in proceeds for operations
Source text in Korean: https://goo.gl/3mJ3ZG
Further company coverage: 004310.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Hyundai Pharmaceutical
See all newsS.Korea morning-after pill makers jump as court strikes down abortion law
S.Korean stocks close little changed; won edges lower
Brief: Acerus Pharmaceuticals Announces Approval Of Natesto In South Korea
Brief: Mithra Pharmaceuticals To Commercialise Estelle In South Korea With Hyundai Pharm
Brief: Hyundai Pharmaceutical to pay annual cash dividend as 50 won/share